TY  - RPRT
TI  - Targeting PRAME directly or via EZH2 inhibition overcomes retinoid resistance and represents a novel therapy for keratinocyte carcinoma.
AU  - Brandon Ramchatesingh
AU  - Amelia Martinez Villarreal
AU  - Philippe Lefrançois
AU  - Jennifer Gantchev
AU  - Sriraam Sivachandran
AU  - Samy Abou Setah
AU  - Ivan V Litvinov
PY  - 2025
DO  - 10.1002/1878-0261.13820
UR  - https://pubmed.ncbi.nlm.nih.gov/40101298/
ID  - 40101298
ER  -